27 September 2024
Agronomics
Limited
("Agronomics" or the "Company")
Shellbay Appoints New Chief
Executive Officer and Change of Director's
Shareholding
The Board of Agronomics
announces
that Shellbay Investments Limited ("Shellbay"), the adviser to the Company
providing portfolio management and investment services, has
appointed Dr Philip Boigner as its interim Chief Executive Officer
with immediate effect.
The appointment of Dr Boigner
follows a strategic review by Mr James Mellon, the non-executive
chair of Agronomics, and indirectly the sole owner of
Shellbay.
Mr Anthony Chow, the former Chief
Executive Officer, has left Shellbay with immediate effect. Mr
Chow, however, will be available to Shellbay, Dr Boigner and the
Company, to ensure an orderly handover or responsibilities, and
continued good relations with the Company's portfolio investee
companies.
Dr Boigner serves as Director at New
Agrarian Company Limited, an active investor in cell agriculture
and fermentation technologies (and an affiliate of Agronomics,
having a number of portfolio companies in common, also advised by
Shellbay). In addition, he has managed capital for sovereign wealth
funds and investment companies with a combined AUM in excess of
many US$ billions. He has global experience and a successful track
record of executing venture capital, private equity, and fund
investments. Dr Boigner has a diverse skill set ranging from
private markets and alternative assets to innovation, ecosystem
building and company turn-arounds.
Shellbay is a related party of the
Company, as Mr Jim Mellon is indirectly the
sole owner of Shellbay and Mr Denham Eke is the sole director of
Shellbay. Mr Mellon and Mr Eke are directors of Agronomics.
Commenting on the appointment of Dr Boigner, Mr Mellon
noted :
"Philip is a first class executive, with years of experience
identifying and realising value from great companies and
technologies. I have worked with him for a number of years at New
Agrarian Company and I have great confidence that he will provide
the necessary skills to bring success to Shellbay, and in
particular the Agronomics portfolio. The share price remains
extremely disappointing notwithstanding general poor market
conditions and sentiment, and the discount to the Company's net
asset value is unacceptable. I would like to thank Anthony Chow for
his work building the portfolio, but between Philip and I,
supported by the rest of the Board, we will ensure investors
understand the great value opportunity that exists currently, the
enormous strides that have been made by companies in the portfolio
recently, and the great potential of these
technologies."
Change in
Director's Shareholding
Separately, following a review of
Jim Mellon's shareholding, the Company has identified an error
which resulted in an understatement of those shares held by
Galloway Limited. Jim Mellon's corrected interest is in a total of
156,106,552 Ordinary Shares, representing 15.46% of the total
issued capital of the Company which remains at 1,009,411,584
Ordinary shares with a nominal value of £0.000001. Of this total,
151,410,944 Ordinary Shares are held by Galloway Limited (not
147,591,813 as previously reported) and 2,313,647 Ordinary Shares
are held by Shellbay, companies which are both indirectly wholly
owned by Jim Mellon, and 2,381,961 Ordinary Shares are held
directly by Mr Mellon. Denham Eke is a director of Galloway Limited
and Shellbay Investments Limited.
THIS ANNOUNCEMENT
CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE
REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN
POSSESSION OF INSIDE INFORMATION.
About
Agronomics
Agronomics is a leading
London-listed company focussing on investment opportunities within
the field of cellular agriculture. The Company has established a
portfolio of over 20 companies in this rapidly advancing sector. It
seeks to invest in companies owning technologies with defensible
intellectual property that offer new ways of producing food and
materials with a focus on products historically derived from
animals. These technologies are driving a major disruption in
agriculture, offering solutions to improve sustainability, as well
as addressing human health, animal welfare and environmental
damage. This disruption will decouple supply chains from the
environment and animals and improve food security for the world's
expanding population. A full list of Agronomics' portfolio
companies is available at https://agronomics.im/.
For further information please
contact:
Agronomics Limited
|
Beaumont
Cornish Limited
|
Canaccord
Genuity Limited
|
Cavendish
Capital Markets Limited
|
Peterhouse Capital Limited
|
SEC
Newgate
|
The
Company
|
Nomad
|
Joint
Broker
|
Joint
Broker
|
Joint
Broker
|
Public
Relations
|
Jim
Mellon
Denham
Eke
|
Roland
Cornish
James
Biddle
|
Andrew
Potts
Harry
Pardoe
Alex
Aylen (Head of Equities)
|
Giles
Balleny
Michael
Johnson
Charlie
Combe
|
Lucy
Williams
Charles
Goodfellow
|
Bob
Huxford
Anthony
Hughes
|
+44 (0)
1624 639396
info@agronomics.im
|
+44 (0)
207 628 3396
|
+44 (0)
207 523 8000
|
+44 (0)
207 397 8900
|
+44 (0)
207 469 0936
|
agronomics@secnewgate.co.uk
|
Nominated Adviser
Beaumont Cornish Limited ("Beaumont
Cornish") is the Company's Nominated Adviser and is authorised and
regulated by the FCA. Beaumont Cornish's responsibilities as the
Company's Nominated Adviser, including a responsibility to advise
and guide the Company on its responsibilities under the AIM Rules
for Companies and AIM Rules for Nominated Advisers, are owed solely
to the London Stock Exchange. Beaumont Cornish is not acting for
and will not be responsible to any other persons for providing
protections afforded to customers of Beaumont Cornish nor for
advising them in relation to the proposed arrangements described in
this announcement or any matter referred to in it.